{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:15:05Z","timestamp":1790313305319,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bja.2018.12.023","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T04:38:23Z","timestamp":1548995903000},"page":"e168-e179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Opioid-induced respiratory depression in humans: a review of pharmacokinetic\u2013pharmacodynamic modelling of reversal"],"prefix":"10.1016","volume":"122","author":[{"given":"Marijke Hyke","family":"Algera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger","family":"van der Schrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"van Velzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Niesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Olofsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2018.12.023_bib1","series-title":"Clinical anesthesia","first-page":"505","article-title":"Opioids","author":"Dahan","year":"2017"},{"key":"10.1016\/j.bja.2018.12.023_bib2","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A\u00a0flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bja.2018.12.023_bib3","first-page":"343","article-title":"The void in opioid research","volume":"588","author":"Anonymous","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bja.2018.12.023_bib4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bja.2018.12.023_bib5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1126\/science.361.6405.831","article-title":"New pain drugs may lower overdose and addiction risk","volume":"361","author":"Service","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bja.2018.12.023_bib6","series-title":"Letter to parliament","year":"2018"},{"key":"10.1016\/j.bja.2018.12.023_bib7","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/ALN.0000000000002184","article-title":"Averting opioid-induced respiratory depression without affecting analgesia","volume":"128","author":"Dahan","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.12.023_bib9","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.286.5444.1566","article-title":"Modulation of respiratory frequency by peptidergic input to rhythmogenic neurons in the pre-B\u00f6tzinger complex","volume":"286","author":"Gray","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bja.2018.12.023_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/ALN.0000000000001719","article-title":"A\u00a0subregion of the parabrachial nucleus partially mediates respiratory rate depression from intravenous remifentanil in young and adult rabbits","volume":"127","author":"Miller","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib11","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1152\/jn.00185.2012","article-title":"Pontine \u03bc-opioid receptors mediate bradypnea caused by intravenous remifentanil infusions at clinically relevant concentrations in dogs","volume":"108","author":"Prkic","year":"2012","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.bja.2018.12.023_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bja.2018.12.023_bib13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00000542-200105000-00021","article-title":"Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice","volume":"94","author":"Dahan","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bja.2018.12.023_bib15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bja.2018.12.023_bib16","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/bph.13809","article-title":"Targeting multiple opioid receptors \u2014 improved analgesics with reduced side effects?","volume":"175","author":"G\u00fcnther","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bja.2018.12.023_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10928-015-9437-x","article-title":"Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models","volume":"42","author":"Danhof","year":"2015","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.bja.2018.12.023_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejps.2016.04.027","article-title":"Systems pharmacology \u2013 towards the modeling of network interactions","volume":"94","author":"Danhof","year":"2016","journal-title":"Eur J Pharmacol Sci"},{"key":"10.1016\/j.bja.2018.12.023_bib19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003088-200746110-00004","article-title":"Mechanism-based PK\/PD modeling of the reversal of buprenorphine-induced respiratory depression by naloxone \u2014 an experimental study in healthy volunteers","volume":"46","author":"Yassen","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2018.12.023_bib20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/ALN.0b013e3181d5e29d","article-title":"Naloxone reversal of morphine- and morphine-6-glucuronide-Induced respiratory depression in humans","volume":"112","author":"Olofsen","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bja.2018.02.021","article-title":"Esketamine counters opioid-induced respiratory depression","volume":"120","author":"Jonkman","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.12.023_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cpt.99","article-title":"Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: a pharmacokinetic\u2013pharmacodynamic modelling study in healthy volunteers","volume":"97","author":"Roozekrans","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2018.12.023_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/cpt.601","article-title":"Doxapram-mediated increase in cardiac output reduces opioid plasma concentrations: a PK-PD\/PK-PD modeling study in healthy volunteers","volume":"102","author":"Roozekrans","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2018.12.023_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.pharmtox.47.120505.105154","article-title":"Mechanism-based pharmacokinetic\u2013pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis","volume":"47","author":"Danhof","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bja.2018.12.023_bib25","first-page":"907","article-title":"Kinetics of interaction between drugs and biological systems","volume":"23","author":"Segre","year":"1968","journal-title":"Farmacol Sci"},{"key":"10.1016\/j.bja.2018.12.023_bib26","first-page":"5","article-title":"The 1982 John Scott award goes to Jack Fishman and Harold Blumber for synthesis and investigation on naloxone","volume":"16","author":"Anonymous","year":"1983","journal-title":"Curr Comments"},{"key":"10.1016\/j.bja.2018.12.023_bib27","first-page":"21","article-title":"Chemistry of narcotic antagonists of the nalorphine type","volume":"8","author":"Robinson","year":"1974","journal-title":"Adv Biochem Psychopharm"},{"key":"10.1016\/j.bja.2018.12.023_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1152\/jappl.1982.52.4.1030","article-title":"No effect of naloxone on hypoxia-induced ventilatory depression in adults","volume":"52","author":"Kagawa","year":"1982","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.bja.2018.12.023_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.clpt.6100262","article-title":"Enhanced buprenorphine analgesia with addition of ultra-low-dose naloxone in healthy subjects","volume":"83","author":"La Vicente","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2018.12.023_bib30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000542-199711000-00011","article-title":"Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate","volume":"87","author":"Gan","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200607000-00012","article-title":"Naloxone reversal of buprenorphine-induced respiratory depression","volume":"205","author":"van Dorp","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib32","series-title":"Basic pharmacology of buprenorphine, Buprenorphine \u2013 the unique opioid analgesic","first-page":"3","author":"Cowan","year":"2005"},{"key":"10.1016\/j.bja.2018.12.023_bib33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bja.2018.06.024","article-title":"Nociceptin\/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic","volume":"121","author":"Calo","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.12.023_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00139709-200625020-00002","article-title":"Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences","volume":"25","author":"M\u00e9garbane","year":"2006","journal-title":"Toxicol Rev"},{"key":"10.1016\/j.bja.2018.12.023_bib35","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/0024-3205(88)90479-1","article-title":"Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats","volume":"43","author":"Abbott","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.bja.2018.12.023_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.clpt.6100025","article-title":"Mechanism based PK\/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers","volume":"81","author":"Yassen","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2018.12.023_bib37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1084674","article-title":"5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia","volume":"301","author":"Manzke","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bja.2018.12.023_bib38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1213\/ANE.0b013e3181eac011","article-title":"Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats","volume":"111","author":"Guenther","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2018.12.023_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ALN.0b013e31823d08fa","article-title":"Selective 5-HT1A-R-agonist repinotan prevents remifentanil-induced ventilatory depression and prolongs antinociception","volume":"116","author":"Guenther","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.clpt.6100018","article-title":"The partial 5-hydroxytryptamine 1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans","volume":"81","author":"Oertel","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2018.12.023_bib41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.clpt.2005.05.010","article-title":"The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression","volume":"78","author":"L\u00f6tsch","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2018.12.023_bib42","doi-asserted-by":"crossref","first-page":"32635","DOI":"10.1165\/rcmb.2014-0374OC","article-title":"Stimulation of respiratory motor output and ventilation in a murine model of Pompe disease by ampakines","volume":"53","author":"ElMallah","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bja.2018.12.023_bib43","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e31819faa2a","article-title":"Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats","volume":"110","author":"Ren","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/rccm.201410-1898OC","article-title":"Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats","volume":"191","author":"Ren","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bja.2018.12.023_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/clpt.2009.194","article-title":"Selective antagonism of opioid-induced respiratory depression by an AMPAKINE molecule in humans without loss of opioid analgesia","volume":"87","author":"Oertel","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2018.12.023_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lfs.2015.02.006","article-title":"Blockade of phosphodiesterase 4 reverses morphine-induced ventilatory disturbances without loss of analgesia","volume":"127","author":"Kimura","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.bja.2018.12.023_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.resp.2010.04.025","article-title":"Methylxanthine reversal\u00a0of\u00a0opioid-evoked inspiratory depression via phosphodiesterase-4 blockade","volume":"172","author":"Ruangkittisakul","year":"2010","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.bja.2018.12.023_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.resp.2014.06.002","article-title":"Methylxanthines reversal of opioid-induced respiratory depression in the neonatal rat: mechanisms and location of action","volume":"200","author":"Mosca","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.bja.2018.12.023_bib49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.biopsych.2015.08.018","article-title":"Chronic administration of the N-methyl-d-aspartate receptor antagonist ketamine improves RETT syndrome phenotype","volume":"79","author":"Patrizi","year":"2016","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.bja.2018.12.023_bib50","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/EJA.0000000000000025","article-title":"The effect of ketamine on hypoventilation during deep sedation with midazolam and propofol: a randomised, double-blind, placebo-controlled trial","volume":"31","author":"De Oliveira","year":"2014","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.bja.2018.12.023_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/ALN.0b013e31823d010a","article-title":"Ketamine activates breathing and abolishes the coupling between loss of consciousness and upper airway dilator muscle dysfunction","volume":"116","author":"Eikermann","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib52","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00000539-200106000-00022","article-title":"The effects of small-dose ketamine on propofol sedation: respiration, postoperative mood, perception, cognition, and pain","volume":"92","author":"Mortero","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2018.12.023_bib53","first-page":"1","article-title":"Towards the sensory nature of the carotid body: Hering, De Castro and Heymans","volume":"3","author":"de Castro","year":"2001","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.bja.2018.12.023_bib54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.resp.2007.02.007","article-title":"Peripheral arterial chemoreceptors and the evolution of the carotid body","volume":"157","author":"Milsom","year":"2007","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.bja.2018.12.023_bib55","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1152\/physrev.00012.2009","article-title":"The ventilatory response to hypoxia in mammals: mechanisms, measurements and analysis","volume":"90","author":"Teppema","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bja.2018.12.023_bib56","first-page":"281","article-title":"Carotid bodies and the integrated cardiorespiratory response to hypoxia","volume":"33","author":"Lindsey","year":"2018","journal-title":"Phsyiology"},{"key":"10.1016\/j.bja.2018.12.023_bib57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature15721","article-title":"Oxygen regulation through an olfactory receptor activated by lactate","volume":"527","author":"Chang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bja.2018.12.023_bib58","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1213\/ANE.0b013e318284469d","article-title":"TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats","volume":"116","author":"Cotton","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2018.12.023_bib59","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/ALN.0000000000000844","article-title":"Identification and characterization of GAL021 as a novel breathing control modulator","volume":"123","author":"Golder","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.12.023_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740338.6.2.125","article-title":"Naloxone treatment in opioid addiction: the risks and benefits","volume":"6","author":"van Dorp","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bja.2018.12.023_bib61","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2146\/ajhp130798","article-title":"Intranasal naloxone administration for treatment of opioid overdose","volume":"71","author":"Robinson","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bja.2018.12.023_bib62","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/add.14033","article-title":"Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: phase 1 healthy volunteer study","volume":"113","author":"McDonald","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.bja.2018.12.023_bib63","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/17425247.2017.1230097","article-title":"Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems","volume":"14","author":"Elzey","year":"2017","journal-title":"Expert Opin Drug Del"},{"key":"10.1016\/j.bja.2018.12.023_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: risks and benefits","volume":"77","author":"Niesters","year":"2014","journal-title":"Br J Clin Pharmacol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709121930008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709121930008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:53:38Z","timestamp":1757789618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000709121930008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S000709121930008X"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2018.12.023","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid-induced respiratory depression in humans: a review of pharmacokinetic\u2013pharmacodynamic modelling of reversal","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2018.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}